Clinical trial
Magnetic Sentinel Lymph Node Mapping in Upper Gastro-Intestinal Cancer: A Feasibility Clinical Investigation
NCT05899985 is registered in ClinicalTrials.gov with Ferronova Pty Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Magnetic Sentinel Lymph Node Mapping in Upper Gastro-Intestinal Cancer: A Feasibility Clinical Investigation
- Lead sponsor
- Ferronova Pty Ltd
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- March 21, 2024
- Completion date
- May 31, 2029
- Enrollment
- 60 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
esophageal cancer, gastric cancer